Iradimed CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
IRMD
Iradimed CORPIRADIMED Corporation has scheduled its 2025 Annual Meeting of Stockholders for June 19, 2025, to elect directors, ratify the appointment of its independent accounting firm, and conduct an advisory vote on executive compensation.
NASDAQ
IRMD
Iradimed CORPIRADIMED Corporation files a supplement to its definitive proxy statement to correct an incorrect date related to security ownership information.
NASDAQ
IRMD
Iradimed CORPIRADIMED Corporation will hold its 2024 Annual Meeting of Stockholders on June 20, 2024, to elect directors, ratify the appointment of its independent accounting firm, and approve executive compensation.